ALNYLAM PHARMACEUTICALS, INC. — EDGAR filing profile
ALNYLAM PHARMACEUTICALS, INC. (ALNY) made 1,000 filings in its most recent EDGAR window (2014-08-26 to 2026-10-06) — about 81 routine filings per year once routine debt and shelf offerings are excluded. 584 of the filings are insider forms (Form 4: 561, Form 3: 22, Form 5: 1), i.e. 58.4% of routine filings.
Of the 1,000 filings in this window, 17 (1.7%) are routine debt or shelf offerings (form 424B*, FWP, S-3*), which are excluded from the routine rate below because large issuers generate them continuously.
Form type
Filings in window
4
561
8-K
141
SC 13G/A
70
144
48
10-Q
36
3
22
CT ORDER
18
DEF 14A
12
10-K
12
DEFA14A
10
UPLOAD
10
SC 13G
8
424B5
8
S-8
7
Activity over the window
Metric
Value
Window covered
2014-08-26 → 2026-10-06
Span
12.11 years
All filings in window
1,000
Routine filings (offerings excluded)
983
Routine filings per year
81
Insider forms as share of routine filings
58.4%
Routine debt/shelf offering share
1.7%
Former names on record: ALNYLAM PHARMACEUTICALS INC